On July 7, 2021, the U.S. Food and Drug Administration (FDA) issued new warnings regarding hydroxyethyl starch (HES) blood volume expanders. Specifically, the FDA is now requiring manufacturers to ...

When a U.S. soldier is wounded in combat, his lost blood is often replaced with Hextend®, a plasma expander developed by BioTime (www.biotimeinc.com). The high molecular weight plasma expander also is ...

BioTime, headquartered in Alameda, California, is a biotechnology company focused on regenerative medicine and blood plasma volume expanders. Its broad platform of stem cell technologies is developed ...

The basic experimental model tested the ability of an infusion of human plasma to expand the normal plasma volume to a hypervolemic state and to maintain this expansion for several hours. The kinetics ...

Intravenous administration of isotonic fluids is the standard emergency treatment in the U.S. for patients with severe blood loss, but UC San Diego bioengineering researchers have reported improved ...

Mar. 23 -- THURSDAY, Dec. 27 (HealthDay News) -- Voluven was approved Thursday by the U.S. Food and Drug Administration to prevent and treat significant loss of blood from surgery. The intravenous ...